Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Aprea Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +3 vs. Q2 2023
- Shares held
- 877.4K
- −4.40K (−0.5%) vs. Q2 2023
- Total value
- $3.66M
- +$884.6K (+31.9%) vs. Q2 2023
- New holders
- 4
- 2 more added
- Sold out
- 1
- 6 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $1.90M |
| Q1 2026 | 22 | $1.71M |
| Q4 2025 | 22 | $1.45M |
| Q3 2025 | 23 | $2.39M |
| Q2 2025 | 23 | $3.07M |
| Q1 2025 | 26 | $3.78M |
| Q4 2024 | 26 | $6.83M |
| Q3 2024 | 22 | $5.50M |
| Q2 2024 | 28 | $8.48M |
| Q1 2024 | 24 | $10.8M |
| Q4 2023 | 20 | $4.36M |
| Q3 2023 | 21 | $3.66M |
| Q2 2023 | 19 | $2.78M |
| Q1 2023 | 18 | $3.77M |
| Q4 2022 | 25 | $521.3K |
| Q3 2022 | 27 | $1.11M |
| Q2 2022 | 34 | $1.52M |
| Q1 2022 | 40 | $4.50M |
| Q4 2021 | 41 | $10.4M |
| Q3 2021 | 39 | $25.6M |
| Q2 2021 | 50 | $31.9M |
| Q1 2021 | 67 | $45.4M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Aprea Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 3 | $13 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 4 | $17 | 0.00% | +4 | New |
| Creative Planning | 25 | $105 | 0.00% | +25 | New |
| Bull Oak Capital, LLC | 39 | $162 | 0.00% | +39 | New |
| Princeton Global Asset Management LLC | 100 | $417 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 200 | $833 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 317 | $1.00K | 0.00% | +194+157.7% | Added |
| Wells Fargo & Company | 270 | $1.13K | 0.00% | −3−1.1% | Reduced |
| MB, Levis & Associates, LLC | 806 | $3.36K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 1,000 | $4.17K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,747 | $7.28K | 0.00% | −1,578−47.5% | Reduced |
| Group One Trading, L.P. | 2,160 | $9.05K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3,250 | $13.5K | 0.00% | +3,250 | New |
| BlackRock Inc. | 9,230 | $38.5K | 0.00% | −13−0.1% | Reduced |
| Morgan Stanley | 14,562 | $60.7K | 0.00% | −722−4.7% | Reduced |
| Geode Capital Management, LLC | 17,473 | $73.2K | 0.00% | −6,117−25.9% | Reduced |
| Vanguard Group Inc | 27,341 | $113.9K | 0.00% | +11,840+76.4% | Added |
| Walleye Capital LLC | 82,356 | $345.1K | 0.01% | −11,271−12.0% | Reduced |
| Worth Venture Partners, LLC | 87,169 | $365.2K | 0.22% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 280,000 | $1.17M | 0.36% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 349,300 | $1.46M | 0.69% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| Kistler-Tiffany Companies, LLC | – | – | – | – | Not filed |